$517 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 120 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 30.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EVH | Buy | EVOLENT HEALTH INCcl a | $16,444,827 | +23.0% | 585,642 | +57.4% | 3.18% | +20.8% |
HQY | Buy | HEALTHEQUITY INC | $15,026,291 | -4.0% | 243,775 | +4.6% | 2.91% | -5.7% |
Buy | R1 RCM INC | $14,810,357 | +17.1% | 1,352,544 | +98.1% | 2.87% | +15.0% | |
BMRN | Sell | BIOMARIN PHARMAC INC | $14,362,342 | +3.8% | 138,780 | -15.0% | 2.78% | +1.9% |
UNH | Sell | UNITEDHEALTH GRP INC | $13,400,300 | -19.9% | 25,275 | -23.7% | 2.59% | -21.3% |
RXDX | Buy | PROMETHEUS BIOSCIENC | $12,343,100 | +102.7% | 112,210 | +8.7% | 2.39% | +99.0% |
NARI | Sell | INARI MED INC | $11,488,025 | -13.2% | 180,743 | -0.9% | 2.22% | -14.8% |
ICLR | Buy | ICON PLC | $11,004,263 | +11.0% | 56,650 | +5.1% | 2.13% | +9.1% |
JNJ | Sell | JOHNSON & JOHNSON | $10,969,965 | -1.0% | 62,100 | -8.5% | 2.12% | -2.8% |
INSM | Buy | INSMED INC | $10,311,518 | -6.9% | 516,092 | +0.4% | 2.00% | -8.6% |
ATRC | ATRICURE INC | $10,053,490 | +13.5% | 226,532 | 0.0% | 1.94% | +11.5% | |
IRTC | Sell | IRHYTHM TECHNOLOGIES | $9,005,059 | -30.2% | 96,136 | -6.6% | 1.74% | -31.4% |
EXEL | Buy | EXELIXIS INC | $8,877,739 | +2.3% | 553,475 | +0.0% | 1.72% | +0.5% |
PTCT | Sell | PTC THERAPEUTICS I | $8,683,331 | -27.6% | 227,491 | -4.8% | 1.68% | -28.9% |
OPCH | New | OPTION CARE HEALTH | $8,229,615 | – | 273,500 | +100.0% | 1.59% | – |
ARVN | Sell | ARVINAS INC | $8,184,640 | -26.3% | 239,247 | -4.1% | 1.58% | -27.6% |
AGLY | Sell | AGILITI INC | $8,126,001 | +1.8% | 498,222 | -10.7% | 1.57% | 0.0% |
SWAV | Buy | SHOCKWAVE MEDICAL | $8,039,351 | -2.3% | 39,100 | +32.1% | 1.56% | -4.1% |
APLS | Buy | APELLIS PHARMACEUTIC | $7,877,501 | -7.0% | 152,340 | +22.9% | 1.52% | -8.6% |
HALO | HALOZYME THERAPEUTIC | $7,818,060 | +43.9% | 137,400 | 0.0% | 1.51% | +41.4% | |
PRVA | Buy | PRIVIA HEALTH GROUP | $7,296,996 | -21.6% | 321,312 | +17.6% | 1.41% | -23.0% |
PRTA | New | PROTHENA CORP PLC | $6,940,800 | – | 115,200 | +100.0% | 1.34% | – |
DNLI | Buy | DENALI THERAPEUTICS | $6,781,469 | -9.2% | 243,850 | +0.2% | 1.31% | -10.8% |
LNTH | Buy | LANTHEUS HLDGS INC | $6,761,730 | -16.9% | 132,687 | +14.7% | 1.31% | -18.4% |
LLY | LILLY ELI & CO | $6,736,944 | +13.1% | 18,415 | 0.0% | 1.30% | +11.2% | |
SBTX | Sell | ARS PHARMACEUTICALS | $6,673,957 | +20.9% | 782,410 | -25.1% | 1.29% | +18.8% |
PFE | PFIZER INC | $6,630,456 | +17.1% | 129,400 | 0.0% | 1.28% | +15.0% | |
ITCI | INTRA CELLULAR THERA | $6,480,054 | +13.7% | 122,450 | 0.0% | 1.25% | +11.7% | |
ALHC | New | ALIGNMENT HEALTHCA | $6,456,240 | – | 549,000 | +100.0% | 1.25% | – |
FOLD | Sell | AMICUS THERAPEUTICS | $6,198,797 | +3.7% | 507,682 | -11.4% | 1.20% | +1.9% |
TVTX | Buy | TRAVERE THERAPEUTICS | $6,147,490 | -0.1% | 292,320 | +17.1% | 1.19% | -1.8% |
MRK | Sell | MERCK & CO INC | $6,102,250 | +22.7% | 55,000 | -4.8% | 1.18% | +20.5% |
ALKS | Sell | ALKERMES PLC | $6,059,547 | +16.8% | 231,900 | -0.2% | 1.17% | +14.8% |
ABBV | Sell | ABBVIE INC | $6,028,053 | -15.3% | 37,300 | -29.7% | 1.17% | -16.9% |
CTIC | Buy | CTI BIOPHARMA CORP | $5,891,603 | +4.5% | 980,300 | +1.2% | 1.14% | +2.7% |
Sell | AMYLYX PHARMACEUTIC | $5,836,253 | +0.9% | 157,950 | -23.1% | 1.13% | -0.9% | |
ALT | Buy | ALTIMMUNE INC | $5,634,125 | +64.0% | 342,500 | +27.3% | 1.09% | +61.0% |
RDNT | New | RADNET INC | $5,591,248 | – | 296,933 | +100.0% | 1.08% | – |
BLU | Buy | BELLUS HEALTH INC | $5,499,418 | -15.2% | 669,029 | +8.9% | 1.06% | -16.7% |
AXNX | Sell | AXONICS INC | $5,480,504 | -31.9% | 87,646 | -23.3% | 1.06% | -33.1% |
ALNY | Buy | ALNYLAM PHARMACUETCL | $5,420,797 | +19.4% | 22,810 | +0.6% | 1.05% | +17.3% |
REPL | New | REPLIMUNE GROUP INC | $5,344,800 | – | 196,500 | +100.0% | 1.03% | – |
BSX | Sell | BOSTON SCIENTIFIC | $5,273,670 | +7.2% | 113,976 | -10.2% | 1.02% | +5.3% |
SGEN | Buy | SEAGEN INC | $5,164,817 | +53.0% | 40,190 | +62.9% | 1.00% | +50.2% |
BPMC | Buy | BLUEPRINT MEDICINES | $5,077,579 | -29.9% | 115,900 | +5.5% | 0.98% | -31.1% |
THC | TENET HEALTHCARE | $4,952,185 | -5.4% | 101,500 | 0.0% | 0.96% | -7.1% | |
RCUS | Buy | ARCUS BIOSCIENCES | $4,931,808 | -17.0% | 238,482 | +5.0% | 0.95% | -18.5% |
AMGN | Buy | AMGEN INC | $4,706,509 | +28.7% | 17,920 | +10.5% | 0.91% | +26.5% |
INSP | Sell | INSPIRE MED SYS INC | $4,584,216 | -38.2% | 18,200 | -56.5% | 0.89% | -39.3% |
SILK | Sell | SILK ROAD MEDICAL | $4,470,529 | -12.9% | 84,589 | -25.8% | 0.86% | -14.4% |
TMO | Buy | THERMO FISHER SCI | $4,386,246 | +48.1% | 7,965 | +36.4% | 0.85% | +45.4% |
KRTX | Buy | KARUNA THERAPEUTICS | $4,285,665 | -1.3% | 21,810 | +12.9% | 0.83% | -3.2% |
TMCI | Sell | TREACE MED CONCEPT | $4,136,453 | -23.1% | 179,924 | -26.2% | 0.80% | -24.5% |
Buy | RALLYBIO CORP | $4,072,684 | +20.6% | 619,891 | +165.6% | 0.79% | +18.5% | |
ZNTL | Buy | ZENTALIS PHARMACEU | $4,048,140 | +211.4% | 201,000 | +235.0% | 0.78% | +205.9% |
IMGN | Sell | IMMUNOGEN INC | $3,987,562 | -1.7% | 803,944 | -5.3% | 0.77% | -3.4% |
ARWR | Sell | ARROWHEAD PHARMACEUT | $3,869,424 | +18.5% | 95,400 | -3.4% | 0.75% | +16.5% |
CYTK | CYTOKINETICS INC | $3,823,679 | -5.4% | 83,450 | 0.0% | 0.74% | -7.2% | |
RCKT | Sell | ROCKET PHARMACEUTICA | $3,733,760 | -13.6% | 190,790 | -29.5% | 0.72% | -15.0% |
BIIB | Buy | BIOGEN INC | $3,697,436 | +4.5% | 13,352 | +0.8% | 0.72% | +2.6% |
OM | Buy | OUTSET MED INC | $3,614,800 | +353.6% | 140,000 | +180.0% | 0.70% | +345.2% |
BMY | Sell | BRISTOL MYERS SQUIBB | $3,597,500 | -22.7% | 50,000 | -23.7% | 0.70% | -24.1% |
OLMA | Buy | OLEMA PHARMACEUTICAL | $3,532,422 | +44.9% | 1,441,805 | +63.3% | 0.68% | +42.5% |
ABT | Sell | ABBOTT LABS | $3,485,613 | -30.4% | 31,748 | -38.6% | 0.67% | -31.6% |
MRNA | Sell | MODERNA INC | $3,182,507 | +47.1% | 17,718 | -3.1% | 0.62% | +44.6% |
IQV | Sell | IQVIA HOLDINGS INC | $3,093,839 | -15.9% | 15,100 | -25.6% | 0.60% | -17.3% |
DHR | Buy | DANAHER CORP | $3,085,508 | +38.5% | 11,625 | +34.8% | 0.60% | +36.0% |
MRTX | Buy | MIRATI THERAPEUTICS | $3,028,792 | -27.1% | 66,846 | +12.3% | 0.59% | -28.4% |
ARQT | Sell | ARCUTIS BIOTHERAPE | $3,017,010 | -28.6% | 203,852 | -7.8% | 0.58% | -29.8% |
PCVX | New | VAXCYTE INC | $2,877,000 | – | 60,000 | +100.0% | 0.56% | – |
NTLA | INTELLIA THERAPEUT | $2,490,448 | -37.6% | 71,380 | 0.0% | 0.48% | -38.8% | |
BEAM | Sell | BEAM THERAPEUTICS | $2,483,485 | -20.7% | 63,500 | -3.3% | 0.48% | -22.0% |
GRTX | New | GALERA THERAPEUTIC | $2,483,332 | – | 1,666,666 | +100.0% | 0.48% | – |
MDT | MEDTRONIC PLC | $2,452,144 | -3.8% | 31,551 | 0.0% | 0.48% | -5.4% | |
EW | New | EDWARDS LIFESCIENCE | $2,380,059 | – | 31,900 | +100.0% | 0.46% | – |
SYK | Sell | STRYKER CORP | $2,273,757 | +8.0% | 9,300 | -10.6% | 0.44% | +6.0% |
GILD | Sell | GILEAD SCIENCES INC | $2,236,393 | -0.4% | 26,050 | -28.4% | 0.43% | -2.0% |
STAA | Sell | STAAR SURGICAL CO | $2,135,760 | -51.6% | 44,000 | -29.6% | 0.41% | -52.5% |
VRTX | Sell | VERTEX PHARMACEUTICL | $2,026,947 | -11.6% | 7,019 | -11.4% | 0.39% | -13.3% |
REGN | Sell | REGENERON PHARMCTCLS | $1,955,238 | -14.5% | 2,710 | -18.4% | 0.38% | -16.2% |
FATE | FATE THERAPEUTICS | $1,846,470 | -55.0% | 183,000 | 0.0% | 0.36% | -55.8% | |
HUM | Sell | HUMANA INC | $1,831,079 | -66.1% | 3,575 | -67.9% | 0.35% | -66.7% |
New | ZYMEWORKS INC | $1,510,095 | – | 192,124 | +100.0% | 0.29% | – | |
New | EXSCIENTIA PLCads | $1,412,972 | – | 265,098 | +100.0% | 0.27% | – | |
SRRK | New | SCHOLAR ROCK HLDG | $1,368,423 | – | 151,207 | +100.0% | 0.26% | – |
AZN | Buy | ASTRAZENECAsp adr | $1,356,678 | +26.8% | 20,010 | +2.6% | 0.26% | +24.6% |
AVIR | New | ATEA PHARMACEUTICALS | $1,353,548 | – | 281,403 | +100.0% | 0.26% | – |
PNT | New | POINT BIOPHARMA GBL | $1,350,677 | – | 185,278 | +100.0% | 0.26% | – |
MGNX | New | MACROGENICS INC | $1,343,476 | – | 200,220 | +100.0% | 0.26% | – |
BGNE | Buy | BEIGENE LIMITEDsp adr | $1,315,241 | +68.8% | 5,980 | +3.5% | 0.26% | +66.7% |
BTAI | New | BIOXCEL THERAPEUTI | $1,313,631 | – | 61,156 | +100.0% | 0.25% | – |
XBI | New | SPDR SER TRs&p biotech | $1,285,006 | – | 15,482 | +100.0% | 0.25% | – |
FDMT | New | 4D MOLECULAR THERA | $1,195,698 | – | 53,836 | +100.0% | 0.23% | – |
BCAB | New | BIOATLA INC | $1,140,926 | – | 138,294 | +100.0% | 0.22% | – |
ITOS | New | ITEOS THERAPEUTICS | $1,128,092 | – | 57,762 | +100.0% | 0.22% | – |
GBIO | New | GENERATION BIO CO | $1,075,983 | – | 273,787 | +100.0% | 0.21% | – |
EFFECTOR THERAPEUTCS | $1,018,819 | -25.3% | 2,382,644 | 0.0% | 0.20% | -26.8% | ||
ILMN | ILLUMINA INC | $934,164 | +6.0% | 4,620 | 0.0% | 0.18% | +4.0% | |
HZNP | Sell | HORIZON THERAPEUTICS | $773,840 | -86.8% | 6,800 | -92.8% | 0.15% | -87.0% |
INCY | Sell | INCYTE CORPORATION | $536,538 | +13.7% | 6,680 | -5.6% | 0.10% | +11.8% |
RDY | Buy | DR REDDYS LABS LTDadr | $517,707 | +9.9% | 10,004 | +11.1% | 0.10% | +7.5% |
UTHR | Sell | UNITED THERAPEUTICS | $504,733 | +25.9% | 1,815 | -5.2% | 0.10% | +24.1% |
RPRX | Buy | ROYALTY PHARMA PLC | $491,629 | +0.7% | 12,440 | +2.5% | 0.10% | -1.0% |
LEGN | LEGEND BIOTECH CORPsp ads | $449,280 | +22.4% | 9,000 | 0.0% | 0.09% | +20.8% | |
SNY | SANOFIsp adr | $431,027 | +27.5% | 8,900 | 0.0% | 0.08% | +23.9% | |
ZLAB | Sell | ZAI LAB LTDadr | $412,055 | -14.0% | 13,422 | -4.1% | 0.08% | -14.9% |
BNTX | BIONTECH SEsp adr | $405,594 | +11.4% | 2,700 | 0.0% | 0.08% | +8.3% | |
SRPT | SAREPTA THERAPEUTICS | $362,824 | +17.0% | 2,800 | 0.0% | 0.07% | +14.8% | |
ARGX | Sell | ARGENX SEsp adr | $352,312 | -21.4% | 930 | -26.8% | 0.07% | -22.7% |
NBIX | Sell | NEUROCRINE BIOSCIENC | $334,432 | +3.2% | 2,800 | -8.2% | 0.06% | +1.6% |
JAZZ | JAZZ PHARMA PLC | $313,841 | +19.3% | 1,970 | 0.0% | 0.06% | +17.3% | |
ASND | Sell | ASCENDIS PHARMA A Ssp adr | $206,400 | +5.8% | 1,690 | -10.6% | 0.04% | +5.3% |
MEDP | Sell | MEDPACE HOLDINGS | $206,038 | +23.4% | 970 | -8.5% | 0.04% | +21.2% |
FUSN | FUSION PHARMACEUTI | $180,486 | +4.9% | 57,297 | 0.0% | 0.04% | +2.9% | |
IONS | IONIS PHARMACEUTICAL | $168,077 | -14.7% | 4,450 | 0.0% | 0.03% | -15.4% | |
New | ROIVANT SCIENCES LTD | $167,790 | – | 21,000 | +100.0% | 0.03% | – | |
RAIN | New | RAIN ONCOLOGY INC | $150,400 | – | 18,800 | +100.0% | 0.03% | – |
GH | GUARDANT HEALTH INC | $129,744 | -49.5% | 4,770 | 0.0% | 0.02% | -51.0% | |
NVCR | NOVOCURE LTD | $117,360 | -3.8% | 1,600 | 0.0% | 0.02% | -4.2% | |
CRSP | CRISPR THERAPEUTICSnamen akt | $101,219 | -37.9% | 2,490 | 0.0% | 0.02% | -37.5% | |
NVAX | Exit | NOVAVAX INC | $0 | – | -2,550 | -100.0% | -0.01% | – |
A | Exit | AGILENT TECHN INC | $0 | – | -1,148 | -100.0% | -0.03% | – |
Exit | JASPER THERAPEUTICS | $0 | – | -400,000 | -100.0% | -0.06% | – | |
ANTM | Exit | ELEVANCE HEALTH INC | $0 | – | -4,250 | -100.0% | -0.38% | – |
MOH | Exit | MOLINA HEALTHCARE | $0 | – | -6,275 | -100.0% | -0.41% | – |
CI | Exit | CIGNA CORP | $0 | – | -7,800 | -100.0% | -0.43% | – |
CERT | Exit | CERTARA INC | $0 | – | -173,129 | -100.0% | -0.45% | – |
CNC | Exit | CENTENE CORP DEL | $0 | – | -45,600 | -100.0% | -0.70% | – |
SGFY | Exit | SIGNIFY HEALTH INC | $0 | – | -150,000 | -100.0% | -0.86% | – |
Exit | CINCOR PHARMA INC | $0 | – | -195,534 | -100.0% | -1.26% | – | |
SYNH | Exit | SYNEOS HEALTH INCcl a | $0 | – | -182,856 | -100.0% | -1.70% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-10
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
PFIZER INC | 35 | Q3 2023 | 6.3% |
MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
SEQUENOM INC | February 12, 2014 | ? | ? |
INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
SC 13G/A | 2023-02-13 |
SC 13G | 2023-02-13 |
13F-HR | 2023-02-10 |
13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.